<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ajmb
   </journal-id>
   <journal-title-group>
    <journal-title>
     American Journal of Molecular Biology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2161-6620
   </issn>
   <issn publication-format="print">
    2161-6663
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ajmb.2025.153018
   </article-id>
   <article-id pub-id-type="publisher-id">
    ajmb-143790
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Biomedical 
     </subject>
     <subject>
       Life Sciences
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Diversity of KIR Genes and Their Association with Human Papillomavirus (HPV) Infection in West Africa
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mah Alima Esther
      </surname>
      <given-names>
       Traore
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Marius Ayaovi
      </surname>
      <given-names>
       Setor
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Teega-Wendé Clarisse
      </surname>
      <given-names>
       Ouedraogo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Théodora Mahoukèdè
      </surname>
      <given-names>
       Zohoncon
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Dorcas
      </surname>
      <given-names>
       Obiri-Yeboah
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Régine
      </surname>
      <given-names>
       Ilboudo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Abel Pegdwendé
      </surname>
      <given-names>
       Sorgho
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Prosper
      </surname>
      <given-names>
       Bado
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Abdoul Karim
      </surname>
      <given-names>
       Ouattara
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Albert Théophane
      </surname>
      <given-names>
       Yonli
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Apollinaire
      </surname>
      <given-names>
       Horo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Moutawakilo
      </surname>
      <given-names>
       Gomina
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff7"> 
      <sup>7</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mady
      </surname>
      <given-names>
       Nayama
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff8"> 
      <sup>8</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Simon
      </surname>
      <given-names>
       Akpona
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff7"> 
      <sup>7</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Simplice Damintoti
      </surname>
      <given-names>
       Karou
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff9"> 
      <sup>9</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Charlemagne
      </surname>
      <given-names>
       Ouedraogo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff10"> 
      <sup>10</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Florencia Wendkuuni
      </surname>
      <given-names>
       Djigma
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Jacques
      </surname>
      <given-names>
       Simpore
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aUniversité Joseph KI-ZERBO, Laboratory of Molecular Biology and Genetics (LABIOGENE), Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aNational Center for Scientific and Technological Research (CNRST) Institute for Research in Applied Sciences and Technologies Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff3">
    <addr-line>
     aFaculty of Medicine, University Saint Thomas d’Aquin, Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff4">
    <addr-line>
     aDepartment of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana
    </addr-line> 
   </aff> 
   <aff id="aff5">
    <addr-line>
     aPietro Annigoni Biomolecular Research Centre (CERBA), Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff6">
    <addr-line>
     aDepartment of Obstetrics and Gynecology, University Félix Houphouët Boigny, UFR Des Sciences Médicales D’Abidjan, Abidjan, Ivory Coast
    </addr-line> 
   </aff> 
   <aff id="aff7">
    <addr-line>
     aFaculty of Medicine, University of Parakou, Parakou, Benin
    </addr-line> 
   </aff> 
   <aff id="aff8">
    <addr-line>
     aFaculty of Health Sciences, University Abdoul Moumouni, Niamey, Niamey
    </addr-line> 
   </aff> 
   <aff id="aff9">
    <addr-line>
     aRegional Center of Excellence in Poultry Science, University of Lomé, Lomé, Togo
    </addr-line> 
   </aff> 
   <aff id="aff10">
    <addr-line>
     aUniversity Joseph KI-ZERBO, Health Sciences Training and Research Unit (UFR/SDS) Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     06
    </day> 
    <month>
     06
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    03
   </issue>
   <fpage>
    262
   </fpage>
   <lpage>
    275
   </lpage>
   <history>
    <date date-type="received">
     <day>
      2,
     </day>
     <month>
      April
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      27,
     </day>
     <month>
      April
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      27,
     </day>
     <month>
      June
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Background</b>: Cervix cancer is the leading cause of cancer death in women in many developing countries, and most commonly the result of human papillomavirus (HPV) infection. Most often, this infection does not lead to injury or cancer - there is viral clearance. We therefore proposed to study the polymorphism of certain genes such as KIR, which seems to have a strong association with HPV infection. We aimed to contribute to the fight against HPV virus infection, through better knowledge of circulating high risk-HPV (HR-HPV) genotype, and the involvement of KIR genes in the progression to cervical cancer. 
    <b>Methods</b>: A total of 1419 samples, taken from the endocervix, were collected. The women came from 6 countries in West Africa (Burkina Faso, Benin, Côte d’Ivoire, Niger, Nigeria, and Togo). These samples were analyzed by multiplex real-time PCR to search for fourteen HR-HPV genotypes, and the KIR genes were characterized using the SSP-PCR method. 
    <b>Results</b>: The results showed that 35.94% (510/1419) of women were infected with HR-HPV. KIR genes were significantly more common in HPV-infected subjects than in controls. The inhibitory KIR genes were, KIR 2DL3 [OR = 2.24, CI (95%) (1.48 - 3.39) p &lt; 0.001], KIR 2DL4 [OR = 3.82, CI (95%) (1.77 - 8.23) p &lt; 0.001], KIR 2DL5A [OR = 1.50, CI (95%) (1.05 - 2.15) p = 0.02], KIR 2DL5B [OR = 1.52, CI (95%) (1.07 - 2.17) p = 0.02], KIR 3DL2 [OR = 3.30, CI (95%) (1.29 - 8.47) p = 0.01] and the pseudogene KIR 2DP1 [OR = 1.97, CI (95%) (1.36 - 2.85) p &lt; 0.001]. 
    <b>Conclusion</b>: This study showed that the KIR genes 3DL3, 2DL4, 2DL5, 3DL2 and 2DP1 seems to be associated with the risk of developing HPV infection.
   </abstract>
   <kwd-group> 
    <kwd>
     HR-HPV
    </kwd> 
    <kwd>
      KIR
    </kwd> 
    <kwd>
      SSP-PCR
    </kwd> 
    <kwd>
      West Africa
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Natural killer cells are innate immune cells that control certain microbial infections and tumors. The function of natural killers (NK) is regulated by a balance between the signals transmitted by the activating receptors, which recognize the ligands located on cells infected by the virus or on cancer cells, and the inhibitory receptors specific to the molecules of the major histocompatibility complex <xref ref-type="bibr" rid="scirp.143790-1">
     [1]
    </xref>. NK cells exhibit a variety of surface receptors that can enhance or decrease their response against the target cell. This includes the killer cell immunoglobulin-like receptors (KIRs), encoded by a region of chromosome 19 called the Leukocyte Receptor Complex (LRC) <xref ref-type="bibr" rid="scirp.143790-2">
     [2]
    </xref>. They are required for natural killer cell function against virus‐infected cells or tumor cells <xref ref-type="bibr" rid="scirp.143790-3">
     [3]
    </xref>. The polymorphism of these KIR receptors has been linked to several diseases, including infection, autoimmunity, and cancer <xref ref-type="bibr" rid="scirp.143790-4">
     [4]
    </xref>. KIR molecules are a family of receptors expressed on the surface of natural killer (NK) cells. They constitute one of the first line defense mechanisms of innate immunity against microorganisms and neoplastic cells <xref ref-type="bibr" rid="scirp.143790-4">
     [4]
    </xref> <xref ref-type="bibr" rid="scirp.143790-5">
     [5]
    </xref>. The KIR polymorphism has been studied in several populations around the world <xref ref-type="bibr" rid="scirp.143790-4">
     [4]
    </xref>-<xref ref-type="bibr" rid="scirp.143790-9">
     [9]
    </xref>. Genotypes have been described in more than 200 diverse populations worldwide <xref ref-type="bibr" rid="scirp.143790-10">
     [10]
    </xref>. KIR receptors have been associated with pathologies induced by HPV infection around the world <xref ref-type="bibr" rid="scirp.143790-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.143790-11">
     [11]
    </xref>-<xref ref-type="bibr" rid="scirp.143790-13">
     [13]
    </xref>, but very few studies, to our knowledge, have been carried out on African populations. This study is the first to be carried out in west Africa on KIR genes in relation to HPV infection. Studies in Africa on this gene are very few and generally concern HIV or HBV infections <xref ref-type="bibr" rid="scirp.143790-14">
     [14]
    </xref>-<xref ref-type="bibr" rid="scirp.143790-18">
     [18]
    </xref>. Due to their function, KIRs may contribute to the clearance of HPV-infected cells and/or dysplastic cells and some studies confirm the association of KIR genes with cervical cancer in women with HPV infection <xref ref-type="bibr" rid="scirp.143790-3">
     [3]
    </xref>. However, since KIR controls the activity of NK cells, variation in the KIR gene can determine the course of the infection <xref ref-type="bibr" rid="scirp.143790-13">
     [13]
    </xref>. It would therefore be interesting to study the KIR genes in relation to HPV infection because this knowledge can be exploited to identify potential immunological biomarkers that can help select patients for suitable therapy <xref ref-type="bibr" rid="scirp.143790-19">
     [19]
    </xref>.</p>
  </sec><sec id="s2">
   <title>2. Materials and Methods</title>
   <sec id="s2_1">
    <title>2.1. Study Site, Type and Population</title>
    <p>The study population consisted of 1419 endocervical samples collected from the cervix. These were two distinct populations at the start, namely 200 samples from a population of sex workers from the city of Ouagadougou and a population of 1219 samples from five countries in West Africa. They are: Côte d’Ivoire (Abidjan), Togo (Kara), Burkina Faso (Ouagadougou), Niger (Niamey), Nigeria (Abuja) and Benin (Parakou). Among the 200 sex workers, there were Beninese, Burkinabè, Ivorian, Nigerian and Togolese women. This was a case-control study. We considered high-risk HPV-positive samples to be the cases and high-risk HPV negative samples to be controls. So, we had a total of 510 cases and 909 controls.</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Collection of Cervical Samples and Screening for Precancerous Lesions</title>
    <p>Samples were collected by endocervical swabbing. The fresh cytological samples from sex workers were collected at the Saint Camille Hospital in Ouagadougou (Burkina Faso). The other samples were collected from a previous study, the project of the Agence universitaire de la Francophonie. These samples were collected in different countries in West Africa. Sex workers were added to this cohort because they are a group of sexually active and predominantly young women <xref ref-type="bibr" rid="scirp.143790-20">
      [20]
     </xref>. The samples obtained were immersed in a transport medium obtained from the DNA-Sorb-A kit (Sacace Biotechnologies, Como, Italy) and stored at −20˚C in the laboratory in the local sites. They were then sent to the Pietro Annigoni Biomolecular Research Center (CERBA) in Ouagadougou and stored there until DNA extraction and characterization of high-risk HPV genotypes. Women were screened for precancerous lesions by visual inspection with acetic acid and Lugol (VIA/VIL) immediately after swabbing.</p>
   </sec>
   <sec id="s2_3">
    <title>2.3. DNA Extraction</title>
    <p>For HPV genotyping, DNA from samples was extracted using the commercial kit called ‘DNA-Sorb-A’ from sacace biotechnology<sup>®</sup> according to the manufacturer’s protocol. For KIR genotyping, human DNA was extracted using the RIDA<sup>®</sup> Xtract Art ‘R-Biopharm’ kit. No. PGZ001 (R-Biopharm AC, Germany). The DNA thus obtained were stored at −20˚C awaiting further analysis.</p>
   </sec>
   <sec id="s2_4">
    <title>2.4. HR-HPV Detection</title>
    <p>The detection of HR-HPV was carried out with the “HPV 14 genotypes Real-TMQuant” kit (SACACE Biotechnologies<sup>®</sup>, Italy) by real-time multiplex PCR. This kit enabled the detection of 14 high-risk HPV genotypes (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68). For PCR amplification each sample was allowed 4 tubes. Each tube contained 15 µl of the reaction mixture and 10 µl of the DNA to be amplified. The mixture consisted of Hot Start DNA polymerase, PCR-buffer-FRT and respectively the E6 and E7 primers of the target regions of 3 to 4 HR-HPV (PCR-mix-1 16, 18, 31, IC; PCR-mix-2 39, 45, 59, IC; PCR-mix-3 33, 35, 56, 68; PCR-mix-4 51, 52, 58, and 66). The amplification program was 1 cycle of 95˚C for 15 minutes, followed by 5 cycles of 95˚C for 5 sec, 60˚C for 20 sec and 72˚C for 15 sec and finally 40 cycles of 95˚C for 5 sec, 60˚C for 30 sec and 72˚C for 15 sec. The results were interpreted with the Microsoft Excel software program named HPV Genotypes 14 Real-TM.xls (SACACE Biotechnologies<sup>®</sup>, Italy) according to the manufacturer’s protocol.</p>
   </sec>
   <sec id="s2_5">
    <title>2.5. KIR Genotyping</title>
    <p>The SSP PCR technique was used to type the fifteen KIR genes (KIR-2DL1, -2DL 2, -2 DL3, -2DL 4, -2 DL5 A, -2 DL 5 B, -2DS 1, -2DS 2, -2DS 3, -2DS 4/1D, -2DS 5, -3DL 1, -3DL 2, -3 DL3, -3DS 1) and the pseudogene KIR-2DP1. This technique allows the amplification of each KIR gene and/or allele using specific primers that bind to the exons of the genes. DNA extracts with a concentration of at least 50 ng/µL were used for the characterization of KIR genes. The characterization of the KIR genes was carried out according to the SSP-PCR method described by Kulkarni et al. in 2010 using the GeneAmp PCR system 9700 device (Applied Biosystem, USA). The PCR was carried out by preparing a reaction mixture of 60 µL per sample as follows: a variable volume of DNA so as to have a quantity of DNA beyond 50 ng, 7.5 µL of 10 × PCR buffer, 2.25 µL of MgCl<sub>2</sub>; 0.6 µL of dNTPs and 0.375 µL of DNA platinum Taq polymerase; the mixture was made up with nuclease-free water to make a volume of 60 µL. Four (4 μL) of the reaction mixture then 1 μL of each mixture of primers or mix was respectively distributed in each well of the PCR 96 plate for a total of 12 wells per sample. Twelve mixes necessary to process each sample were prepared according to the method of Kulkani et al. (Kulkarni et al., 2010) or each mix included two to three pairs of primers. The classic PCR Thermocycler ‘Gene Amp PCR System 9700 (Applied Biosystem, USA)’ was programed for the activation of Taq polymerase at 94˚C for 3 minutes followed by 5 cycles at 94˚C for 15 sec, 65˚C for 15 sec, 72˚C for 30 sec; 21 cycles at 94˚C for 15 sec, 60˚C for 15 sec, 72˚C for 30 sec; 4 cycles at 94˚C for 15 sec, 55˚C for 1 mn, 72˚C for 2 mn and finally a final extension step at 72˚C for 7min. Then PCR products were run by electrophoresis on 3% agarose gel and visualized under UV light at 312 nm.</p>
   </sec>
   <sec id="s2_6">
    <title>2.6. Data Analysis</title>
    <p>Statistical analysis and interpretation of data were performed using Statistical Package for Social Sciences (SPSS) software version 20.0, Epi Info 7 and Microsoft Office Excel 2013. Chi-square test was used for comparison of proportions. The difference was significant for p &lt; 0.05. The estimate of carrier frequencies for each KIR gene was determined by direct counting. The genotypic profiles were used to assess haplotypes A and B. We were thus able to determine the homozygous AA and BB frequencies and the heterozygous AB frequencies, then deduce the frequencies of the haplotypes.</p>
   </sec>
   <sec id="s2_7">
    <title>2.7. Ethical Considerations</title>
    <p>This study received the agreement of the Ethics Committee for Health Research of Burkina Faso (CERS) (deliberation n˚ 2018-01-012). Respect of confidentiality and anonymity in relation to the information provided was essential.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results</title>
   <sec id="s3_1">
    <title>3.1. Socio-Demographic Characteristics of Study Participants</title>
    <p>The socio-demographic characteristics of the population studied are given in <xref ref-type="table" rid="table1">
      Table 1
     </xref>. Of the 1419 participants, 510 (35.94%) were tested positive for HPV-HR and 909 (64.06%) were HR-HPV negative. The age of the women ranged from 16 to 67 years with an average of 34.50 ± 10.14 years. Sixty seven (67.25)% were between 25 and 45 years old. More than half of the women (54.12%) were married and most had reached the secondary school level. The majority of women in the study were Burkinabe which is the country where the study was conducted (32.55%), followed by women from Togo (17.25%), Côte d’Ivoire (17.06%), Benin (16.86%), Nigeria (10%) and finally Niger (6.28%).</p>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.143790-"></xref>Table 1. Socio-demographic characteristics Representation of characteristics of HPV-infected and HPV-uninfected women in the study population, according to age, country, marital status, education level and Lugol’s test results IVA IVL.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td rowspan="2" class="acenter" width="32.07%"><p style="text-align:center">Variable</p></td> 
       <td class="custom-bottom-td acenter" width="12.22%"><p style="text-align:center">HPV+</p></td> 
       <td class="custom-bottom-td acenter" width="21.40%"><p style="text-align:center">HPV−</p></td> 
       <td class="custom-bottom-td acenter" width="18.34%"><p style="text-align:center">Total</p></td> 
       <td rowspan="2" class="acenter" width="15.97%"><p style="text-align:center">p-value</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="12.22%"><p style="text-align:center">N = 510 (%)</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="21.40%"><p style="text-align:center">N = 909 (%)</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="18.34%"><p style="text-align:center">N = 1419 (%)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="5"><p style="text-align:center">Age (years)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="32.07%"><p style="text-align:center">&lt; 25</p></td> 
       <td class="custom-top-td acenter" width="12.22%"><p style="text-align:center">99 (19.41)</p></td> 
       <td class="custom-top-td acenter" width="21.40%"><p style="text-align:center">122 (13.42)</p></td> 
       <td class="custom-top-td acenter" width="18.34%"><p style="text-align:center">221 (15.57)</p></td> 
       <td rowspan="3" class="custom-top-td acenter" width="15.97%"><p style="text-align:center">0.010</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">25 - 45</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">343 (67.25)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">658 (72.39)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">1001 (70.52)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="32.07%"><p style="text-align:center">&gt;45</p></td> 
       <td class="custom-bottom-td acenter" width="12.22%"><p style="text-align:center">68 (13.34)</p></td> 
       <td class="custom-bottom-td acenter" width="21.40%"><p style="text-align:center">129 (14.19)</p></td> 
       <td class="custom-bottom-td acenter" width="18.34%"><p style="text-align:center">197 (13.88)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="100.00%" colspan="5"><p style="text-align:center">Country</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="32.07%"><p style="text-align:center">Benin</p></td> 
       <td class="custom-top-td acenter" width="12.22%"><p style="text-align:center">86 (16.86)</p></td> 
       <td class="custom-top-td acenter" width="21.40%"><p style="text-align:center">167 (18.37)</p></td> 
       <td class="custom-top-td acenter" width="18.34%"><p style="text-align:center">253 (17.83)</p></td> 
       <td rowspan="6" class="custom-top-td acenter" width="15.97%"><p style="text-align:center">˂0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Burkina</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">166 (32.55)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">161 (17.71)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">327 (23.04)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Côte d’Ivoire</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">87 (17.06)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">168 (18.48)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">255 (17.97)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Niger</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">32 (6.28)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">222 (24.42)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">254 (17.90)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Nigéria</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">51 (10)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">35 (3.85)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">86 (6.06)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="32.07%"><p style="text-align:center">Togo</p></td> 
       <td class="custom-bottom-td acenter" width="12.22%"><p style="text-align:center">88 (17.25)</p></td> 
       <td class="custom-bottom-td acenter" width="21.40%"><p style="text-align:center">156 (17.17)</p></td> 
       <td class="custom-bottom-td acenter" width="18.34%"><p style="text-align:center">244 (17.20)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="5"><p style="text-align:center">Marital status</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="32.07%"><p style="text-align:center">Single</p></td> 
       <td class="custom-top-td acenter" width="12.22%"><p style="text-align:center">211 (41.37)</p></td> 
       <td class="custom-top-td acenter" width="21.40%"><p style="text-align:center">193 (21.23)</p></td> 
       <td class="custom-top-td acenter" width="18.34%"><p style="text-align:center">404 (28.47)</p></td> 
       <td class="custom-top-td acenter" width="15.97%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Divorced</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">7 (1.37)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">5 (0.55)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">12 (0.85)</p></td> 
       <td rowspan="3" class="acenter" width="15.97%"><p style="text-align:center">˂0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Married</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">276 (54.12)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">686 (75.47)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">962 (67.80)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="32.07%"><p style="text-align:center">Widow</p></td> 
       <td class="custom-bottom-td acenter" width="12.22%"><p style="text-align:center">16 (3.14)</p></td> 
       <td class="custom-bottom-td acenter" width="21.40%"><p style="text-align:center">25 (2.75)</p></td> 
       <td class="custom-bottom-td acenter" width="18.34%"><p style="text-align:center">41 (2.88)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="100.00%" colspan="5"><p style="text-align:center">Educational level</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="32.07%"><p style="text-align:center">Illiterate</p></td> 
       <td class="custom-top-td acenter" width="12.22%"><p style="text-align:center">135 (26.47)</p></td> 
       <td class="custom-top-td acenter" width="21.40%"><p style="text-align:center">296 (32.56)</p></td> 
       <td class="custom-top-td acenter" width="18.34%"><p style="text-align:center">431 (30.37)</p></td> 
       <td rowspan="2" class="custom-top-td acenter" width="15.97%"><p style="text-align:center">0.010</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="32.07%"><p style="text-align:center">Educated</p></td> 
       <td class="custom-bottom-td acenter" width="12.22%"><p style="text-align:center">375 (73.53)</p></td> 
       <td class="custom-bottom-td acenter" width="21.40%"><p style="text-align:center">613 (67.44)</p></td> 
       <td class="custom-bottom-td acenter" width="18.34%"><p style="text-align:center">988 (69.63)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="5"><p style="text-align:center">VIA</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="32.07%"><p style="text-align:center">Positif</p></td> 
       <td class="custom-top-td acenter" width="12.22%"><p style="text-align:center">51 (10)</p></td> 
       <td class="custom-top-td acenter" width="21.40%"><p style="text-align:center">48 (5.28)</p></td> 
       <td class="custom-top-td acenter" width="18.34%"><p style="text-align:center">99 (6.97)</p></td> 
       <td rowspan="3" class="custom-top-td acenter" width="15.97%"><p style="text-align:center">0.003</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Négatif</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">458 (89.8)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">857 (94.28)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">1315 (92.67)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="32.07%"><p style="text-align:center">Unrealized</p></td> 
       <td class="custom-bottom-td acenter" width="12.22%"><p style="text-align:center">1 (0.2)</p></td> 
       <td class="custom-bottom-td acenter" width="21.40%"><p style="text-align:center">4 (0.44)</p></td> 
       <td class="custom-bottom-td acenter" width="18.34%"><p style="text-align:center">5 (0.35)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="5"><p style="text-align:center">VIL</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="32.07%"><p style="text-align:center">Positif</p></td> 
       <td class="custom-top-td acenter" width="12.22%"><p style="text-align:center">31 (6.08)</p></td> 
       <td class="custom-top-td acenter" width="21.40%"><p style="text-align:center">44 (4.84)</p></td> 
       <td class="custom-top-td acenter" width="18.34%"><p style="text-align:center">75 (5.28)</p></td> 
       <td rowspan="3" class="custom-top-td acenter" width="15.97%"><p style="text-align:center">0.400</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Négatif</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">478 (93.72)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">861 (94.72)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">1339 (94.36)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="32.07%"><p style="text-align:center">Unrealized</p></td> 
       <td class="acenter" width="12.22%"><p style="text-align:center">1 (0.2)</p></td> 
       <td class="acenter" width="21.40%"><p style="text-align:center">4 (0.44)</p></td> 
       <td class="acenter" width="18.34%"><p style="text-align:center">5 (0.35)</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
   <sec id="s3_2">
    <title>3.2. Prevalence of HR-HPV</title>
    <p>HPV research results showed that 35.94% (510/1419) of women were infected with HR HPV. <xref ref-type="fig" rid="fig1">
      Figure 1
     </xref> shows the distribution of these genotypes. The most frequent was HPV 68 (11.33%), HPV 52 (10.86%), HPV 45 (9.22%) and HPV 66 (8.86%). HPV 16 and HPV 33 were the least represented in the women in this study with 2.24% and 1.30% respectively.</p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>Figure 1. HR-HPV genotypes distribution.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1070592-rId30.jpeg?20250630053043" />
    </fig>
    <p>Percentage of circulating HR-HPV in the study population from highest to lowest</p>
   </sec>
   <sec id="s3_3">
    <title>3.3. KIR Gene Distribution in Study Population</title>
    <p>We report the frequencies of 15 KIR genes and one pseudogene in a West African population of sexually active women. Analysis showed that the KIR inhibitory KIR genes 2DL1, 2DL4, 3DL2, 3DL3 and the KIR 2DS4 activator gene were present in over 90% of subjects (cases and controls). The KIR 3DS1 gene was the least prevalent with 7.20% in HPV infected subjects and 7.14% in controls. By comparing the frequencies of KIR genes between groups infected with HPV and groups not infected with HPV, in order to determine the association between the presence of KIR genes and HPV status (<xref ref-type="table" rid="table2">
      Table 2
     </xref>), we found that some KIRs genes were significantly more common in HPV infected subjects than in controls. These are the inhibitory KIR genes, KIR 2DL3 [OR = 2.24, CI (95%) (1.48 - 3.39) p &lt; 0.001], KIR 2DL4 [OR = 3.82, CI (95% ) (1.77 - 8.23) p &lt; 0.001], KIR 2DL5A [OR = 1.50, CI (95%) (1.05 - 2.15) p = 0.02], KIR 2DL5B [OR = 1.52, CI (95%) (1.07 - 2.17) p = 0.02], KIR 3DL2 [OR = 3.30, CI (95%) (1.29 - 8.47) p = 0.01] and the pseudogene KIR 2DP1 [OR = 1.97, CI (95%) (1.36 - 2.85) p &lt; 0.001]. We have grouped the KIR genes into AA, AB or BB haplotypes. These haplotypes were determined according to criteria adopted by Middleton on the Interactive Allele Frequency website (http://www.allelefrequencies.net). Analyzes showed that the AB haplotype was statistically more frequent in cases than in controls [OR = 1.75, CI (95%) (1.23 - 2.50) p = 0.001]. The BB haplotype, on the other hand, was statistically more frequent (p = 0.003) in women not infected with HPV than in those infected with HPV [OR = 0.50, CI (95%) (1.23 - 2.55) p = 0.001].</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.143790-"></xref>Table 2. KIR Frequency and their association with HPV status.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td rowspan="2" class="acenter" width="24.71%"><p style="text-align:center">KIR</p></td> 
       <td class="custom-bottom-td acenter" width="13.95%"><p style="text-align:center">HPV<sup>+</sup></p></td> 
       <td class="custom-bottom-td acenter" width="16.10%"><p style="text-align:center">HPV<sup>−</sup></p></td> 
       <td rowspan="2" class="acenter" width="12.89%"><p style="text-align:center">OR</p></td> 
       <td rowspan="2" class="acenter" width="19.14%"><p style="text-align:center">(95% CI)</p></td> 
       <td rowspan="2" class="acenter" width="13.21%"><p style="text-align:center">p-value</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="13.95%"><p style="text-align:center">N = 264 (%)</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="16.10%"><p style="text-align:center">N = 252 (%)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="6"><p style="text-align:center">Inhibitors</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="24.71%"><p style="text-align:center">2DL1</p></td> 
       <td class="custom-top-td acenter" width="13.95%"><p style="text-align:center">260 (98.48)</p></td> 
       <td class="custom-top-td acenter" width="16.10%"><p style="text-align:center">248 (98.41)</p></td> 
       <td class="custom-top-td acenter" width="12.89%"><p style="text-align:center">1.04</p></td> 
       <td class="custom-top-td acenter" width="19.14%"><p style="text-align:center">0.25 - 4.23</p></td> 
       <td class="custom-top-td acenter" width="13.21%"><p style="text-align:center">0001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DL2</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">118 (44.7)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">106 (42.06)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1.11</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">0.78 - 1.57</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.500</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DL3</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">218 (82.58)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">171 (67.86)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">2.24</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">1.48 - 3.39</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DL4</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">255 (96.59)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">222 (88.1)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">3.82</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">1.77 - 8.23</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DL5A</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">117 (44.32)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">87 (34.52)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1.5</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">1.05 - 2.15</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.020</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DL5B</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">120 (45.45)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">89 (35.32)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1.52</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">1.07 - 2.17</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.020</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">3DL1</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">263 (99.62)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">251 (99.6)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1.04</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">0.06 - 16.84</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">3DL2</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">258 (97.73)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">234 (92.86)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">3.3</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">1.29 - 8.47</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.010</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="24.71%"><p style="text-align:center">3DL3</p></td> 
       <td class="custom-bottom-td acenter" width="13.95%"><p style="text-align:center">261 (98.86)</p></td> 
       <td class="custom-bottom-td acenter" width="16.10%"><p style="text-align:center">242 (96.03)</p></td> 
       <td class="custom-bottom-td acenter" width="12.89%"><p style="text-align:center">3.59</p></td> 
       <td class="custom-bottom-td acenter" width="19.14%"><p style="text-align:center">0.97 - 13.21</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.050</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="6"><p style="text-align:center">Activators</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="24.71%"><p style="text-align:center">2DS1</p></td> 
       <td class="custom-top-td acenter" width="13.95%"><p style="text-align:center">36 (13.64)</p></td> 
       <td class="custom-top-td acenter" width="16.10%"><p style="text-align:center">21 (8.33)</p></td> 
       <td class="custom-top-td acenter" width="12.89%"><p style="text-align:center">1.73</p></td> 
       <td class="custom-top-td acenter" width="19.14%"><p style="text-align:center">0.98 - 3.06</p></td> 
       <td class="custom-top-td acenter" width="13.21%"><p style="text-align:center">0.060</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DS2</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">122 (46.21)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">116 (46.03)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">0.71 - 1.42</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DS3</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">80 (30.3)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">58 (23.02)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1.45</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">0.98 - 2.15</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.070</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DS4</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">256 (96.97)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">242 (96.03)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1.32</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">0.51 - 3.40</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.600</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">2DS5</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">88 (33.33)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">71 (28.17)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1.27</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">0.87 - 1.85</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.200</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="24.71%"><p style="text-align:center">3DS1</p></td> 
       <td class="custom-bottom-td acenter" width="13.95%"><p style="text-align:center">19 (7.2)</p></td> 
       <td class="custom-bottom-td acenter" width="16.10%"><p style="text-align:center">18 (7.14)</p></td> 
       <td class="custom-bottom-td acenter" width="12.89%"><p style="text-align:center">1.01</p></td> 
       <td class="custom-bottom-td acenter" width="19.14%"><p style="text-align:center">0.51 - 1.96</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0001</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="6"><p style="text-align:center">Pseudogene</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="24.71%"><p style="text-align:center">2DP1</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="13.95%"><p style="text-align:center">193 (73.11)</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="16.10%"><p style="text-align:center">146 (57.94)</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="12.89%"><p style="text-align:center">1.97</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="19.14%"><p style="text-align:center">1.36 - 2.85</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="13.21%"><p style="text-align:center">&lt;0.001</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="6"><p style="text-align:center">Haplotype</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="24.71%"><p style="text-align:center">AA</p></td> 
       <td class="custom-top-td acenter" width="13.95%"><p style="text-align:center">90 (34.09)</p></td> 
       <td class="custom-top-td acenter" width="16.10%"><p style="text-align:center">89 (35.32)</p></td> 
       <td class="custom-top-td acenter" width="12.89%"><p style="text-align:center">0.94</p></td> 
       <td class="custom-top-td acenter" width="19.14%"><p style="text-align:center">0.65 - 1.36</p></td> 
       <td class="custom-top-td acenter" width="13.21%"><p style="text-align:center">0.700</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">AB</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">127 (48.11)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">87 (34.52)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">1.75</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">1.23 - 2.50</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="24.71%"><p style="text-align:center">BB</p></td> 
       <td class="acenter" width="13.95%"><p style="text-align:center">47 (17.8)</p></td> 
       <td class="acenter" width="16.10%"><p style="text-align:center">76 (30.16)</p></td> 
       <td class="acenter" width="12.89%"><p style="text-align:center">0.5</p></td> 
       <td class="acenter" width="19.14%"><p style="text-align:center">0.33 - 0.75</p></td> 
       <td class="acenter" width="13.21%"><p style="text-align:center">0.001</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
   <sec id="s3_4">
    <title>3.4. KIRs Gene and their Association with HR-HPV Genotypes</title>
    <p>A separate analysis of samples on the basis that induced HPV 16/18 infections may be particularly resistant to NK cell cytotoxicity was conducted. HR-HPV infections were divided into two distinct groups: those induced by genotypes 16/18 that are 38 (14.40%) on the one hand and infections induced by other genotypes that are 226 (85.60%) on the other hand. Possible associations were sought between KIR genes and different HR-HPV genotypes. Our results showed a significant association of the KIR2DL5 gene with induced HPV 16/18 infection compared to other HPV genotypes [OR = 0.43, CI (95%) (0.20 - 0.92) p = 0.03] (<xref ref-type="table" rid="table3">
      Table 3
     </xref>).</p>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.143790-"></xref>Table 3. Association between KIR genes and HR-HPV genotypes.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td rowspan="2" class="acenter" width="16.23%"><p style="text-align:center">KIR</p></td> 
       <td class="custom-bottom-td acenter" width="22.70%"><p style="text-align:center">HPV16/18+</p></td> 
       <td class="custom-bottom-td acenter" width="19.90%"><p style="text-align:center">Other HR-HPV</p></td> 
       <td rowspan="2" class="acenter" width="12.55%"><p style="text-align:center">OR</p></td> 
       <td rowspan="2" class="acenter" width="17.86%"><p style="text-align:center">(95% CI)</p></td> 
       <td rowspan="2" class="acenter" width="10.76%"><p style="text-align:center">p-value</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="22.70%"><p style="text-align:center">N = 38 (%)</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="19.90%"><p style="text-align:center">N = 226 (%)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="6"><p style="text-align:center">Inhibitors</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="16.23%"><p style="text-align:center">2DL1</p></td> 
       <td class="custom-top-td acenter" width="22.70%"><p style="text-align:center">38 (100)</p></td> 
       <td class="custom-top-td acenter" width="19.90%"><p style="text-align:center">220 (97.35)</p></td> 
       <td class="custom-top-td acenter" width="12.55%"><p style="text-align:center">-</p></td> 
       <td class="custom-top-td acenter" width="17.86%"><p style="text-align:center">-</p></td> 
       <td class="custom-top-td acenter" width="10.76%"><p style="text-align:center">0.500</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DL2</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">12 (31.58)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">90 (39.82)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">0.69</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.33 - 1.45</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.300</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DL3</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">31 (81.58)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">169 (74.78)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">1.49</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.62 - 3.57</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.400</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DL4</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">32 (84.21)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">197 (87.17)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">0.78</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.30 - 2.04</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.600</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DL5A</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">11 (28.95)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">109 (48.23)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">0.43</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.20 - 0.92</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.030</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DL5B</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">11 (28.95)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">109 (48.23)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">0.43</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.20 - 0.92</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.030</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">3DL1</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">36 (94.74)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">215 (95.13)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">0.92</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.19 - 4.32</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0001</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">3DL2</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">35 (92.11)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">207 (91.59)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">1.07</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.30 - 3.81</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0001</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="16.23%"><p style="text-align:center">3DL3</p></td> 
       <td class="custom-bottom-td acenter" width="22.70%"><p style="text-align:center">38 (100)</p></td> 
       <td class="custom-bottom-td acenter" width="19.90%"><p style="text-align:center">220 (97.35)</p></td> 
       <td class="custom-bottom-td acenter" width="12.55%"><p style="text-align:center">0.82</p></td> 
       <td class="custom-bottom-td acenter" width="17.86%"><p style="text-align:center">0.22 - 3.01</p></td> 
       <td class="custom-bottom-td acenter" width="10.76%"><p style="text-align:center">0.700</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="6"><p style="text-align:center">Activators</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="16.23%"><p style="text-align:center">2DS1</p></td> 
       <td class="custom-top-td acenter" width="22.70%"><p style="text-align:center">6 (15.79)</p></td> 
       <td class="custom-top-td acenter" width="19.90%"><p style="text-align:center">30 (13.27)</p></td> 
       <td class="custom-top-td acenter" width="12.55%"><p style="text-align:center">1.22</p></td> 
       <td class="custom-top-td acenter" width="17.86%"><p style="text-align:center">0.47 - 3.17</p></td> 
       <td class="custom-top-td acenter" width="10.76%"><p style="text-align:center">0.600</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DS2</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">11 (28.95)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">96 (42.48)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">0.55</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.26 - 1.16</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.100</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DS3</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">7 (18.42)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">61 (26.99)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">0.61</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.25 - 1.45</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.300</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DS4</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">37 (97.37)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">204 (90.27)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">3.99</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.52 - 30.51</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.200</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="16.23%"><p style="text-align:center">2DS5</p></td> 
       <td class="acenter" width="22.70%"><p style="text-align:center">7 (18.42)</p></td> 
       <td class="acenter" width="19.90%"><p style="text-align:center">70 (30.97)</p></td> 
       <td class="acenter" width="12.55%"><p style="text-align:center">0.5</p></td> 
       <td class="acenter" width="17.86%"><p style="text-align:center">0.21 - 1.19</p></td> 
       <td class="acenter" width="10.76%"><p style="text-align:center">0.100</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="16.23%"><p style="text-align:center">3DS1</p></td> 
       <td class="custom-bottom-td acenter" width="22.70%"><p style="text-align:center">1 (2.63)</p></td> 
       <td class="custom-bottom-td acenter" width="19.90%"><p style="text-align:center">15 (6.64)</p></td> 
       <td class="custom-bottom-td acenter" width="12.55%"><p style="text-align:center">0.38</p></td> 
       <td class="custom-bottom-td acenter" width="17.86%"><p style="text-align:center">0.04 - 2.96</p></td> 
       <td class="custom-bottom-td acenter" width="10.76%"><p style="text-align:center">0.400</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="100.00%" colspan="6"><p style="text-align:center">Pseudogène</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="16.23%"><p style="text-align:center">2DP1</p></td> 
       <td class="custom-top-td acenter" width="22.70%"><p style="text-align:center">30 (78.95)</p></td> 
       <td class="custom-top-td acenter" width="19.90%"><p style="text-align:center">163 (72.12)</p></td> 
       <td class="custom-top-td acenter" width="12.55%"><p style="text-align:center">1.44</p></td> 
       <td class="custom-top-td acenter" width="17.86%"><p style="text-align:center">0.63 - 3.33</p></td> 
       <td class="custom-top-td acenter" width="10.76%"><p style="text-align:center">0.400</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>The objective of this study was to investigate the involvement of the KIR genes in Human Papillomavirus (HPV) infections in women in West Africa. Given the sample size, we combined the results for better understanding. The most prevalent genotypes found were HPV 68 (11.33%), HPV 52 (10.86%), HPV 45 (9.22%), followed by genotypes HPV 66 (8.86%), HPV 56 (8.03%), HPV 31 (7.67%), HPV 35, 51, 58, (7.32%), HPV 59 (7.20%), HPV 39 (5.90%); finally, HPV 18 (5.43%), HPV 16 (2.24%) and HPV 33 (1.30%). The HPV 16 and HPV 18 genotypes are among the lowest prevalence. Similar results were found in previous studies in Burkina Faso <xref ref-type="bibr" rid="scirp.143790-21">
     [21]
    </xref>-<xref ref-type="bibr" rid="scirp.143790-27">
     [27]
    </xref>. The high prevalence of high-risk genotypes other than 16 and 18 had been found in cases of precancerous and cancerous lesions in Burkina Faso and Benin <xref ref-type="bibr" rid="scirp.143790-28">
     [28]
    </xref> <xref ref-type="bibr" rid="scirp.143790-29">
     [29]
    </xref>. In this study, the prevalence of HR-HPV was 35.94%. These results were higher than those found by Traore et al. in Bobo-Dioulasso which was 25.40% <xref ref-type="bibr" rid="scirp.143790-25">
     [25]
    </xref>. While recently, Salambanga et al. in 2019 found a high prevalence of HR-HPV of 52.56% in the city of Ouagadougou <xref ref-type="bibr" rid="scirp.143790-30">
     [30]
    </xref>. This high prevalence can also be explained by the fact that the cohort of women included sex workers where there was a high rate of HPV <xref ref-type="bibr" rid="scirp.143790-20">
     [20]
    </xref>. Fortunately, not all of these HPV-HR infections systematically progress to cervical cancer because of the human factors that regulate clearance. Knowing that the KIR genes are essential in the regulation of the activation of NK cells, it is therefore interesting to ask whether they would potentially have an influence on the infection due to HPV and on the development of precancerous lesions and even of Cancer, because NK cells are the first line of defense against any viral infection and newly formed tumor cells <xref ref-type="bibr" rid="scirp.143790-31">
     [31]
    </xref>. Our results found that the frequency of KIR genes seem quite close to those found in the literature. The KIR 3DL1 gene is found in virtually all subjects; this is a gene that seems to be unique to West Africa <xref ref-type="bibr" rid="scirp.143790-18">
     [18]
    </xref>. Contreras had already encountered it in a population of black Mexicans with a frequency of 100% <xref ref-type="bibr" rid="scirp.143790-32">
     [32]
    </xref>. This was confirmed by Augusto who showed that the KIR 3DL1 gene has a high frequency in Africans <xref ref-type="bibr" rid="scirp.143790-33">
     [33]
    </xref>. Denis et al. Also found that the KIR 2DS4 activator KIR gene is overrepresented in the Senegalese population <xref ref-type="bibr" rid="scirp.143790-34">
     [34]
    </xref>. Next to these genes, which have a high frequency, we notice the KIR 3DS1 gene which is less prevalent in most black African populations, corroborating our results <xref ref-type="bibr" rid="scirp.143790-35">
     [35]
    </xref>. A study of 492 subjects from Kampala, Uganda, indicating that African populations have lower frequencies of telomeric region B and higher frequencies from centromeric region B compared to European populations. This is also the case in South Africa, were in a study involving 167 blacks, the KIR 2DS1 and 3DS1 genes were infrequent <xref ref-type="bibr" rid="scirp.143790-36">
     [36]
    </xref>. These different data on the KIR genes comfort us because it shows that our results agree with the mapping that already exists around the world. Black Africa has its peculiarities, as does white Africa <xref ref-type="bibr" rid="scirp.143790-6">
     [6]
    </xref> <xref ref-type="bibr" rid="scirp.143790-33">
     [33]
    </xref> <xref ref-type="bibr" rid="scirp.143790-34">
     [34]
    </xref> <xref ref-type="bibr" rid="scirp.143790-37">
     [37]
    </xref>. We also found that the KIR 2DL5 gene was less prevalent (P = 0.03) in the HPV 16/18 group than in the group made up of other HR-HPV. Also the KIR genes 2DL3, 2DL4, 2DL5, 3DL2 and the pseudogene 2DP1 were more prevalent among cases than in subjects not infected with HPV. This could indicate possible protection against HPV infection. In a cohort study of 65 women with CIN and 150 controls in northern Sweden, Arnheim et al., found 70 different genotypes and only one genotype A was associated with increased risk of CIN including KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL4, KIR3DL1, KIR3DL2, KIR3DL3 and KIR2DS4 (OR 6.7; 95% CI 1.7 - 26.3) and the KIR 2DL5 B gene appears to be related to the disease. And there was no association between the KIR genes and the type of HPV <xref ref-type="bibr" rid="scirp.143790-11">
     [11]
    </xref>. As for the Brestovac team in Western Australia, it had enrolled 147 CIN patients and 187 controls. CIN 2 and 3 were weakly associated with the absence of KIR 2DL2 AND KIR 2DS2, but this value was insignificant. And no difference was observed between KIR frequencies, CINs and HPV genotypes <xref ref-type="bibr" rid="scirp.143790-13">
     [13]
    </xref>. Tembhurne found that the number of activating KIR genes was higher in women with cancer, as in our study in infected women. The fact that there are high numbers of activating KIR genes may translate into the possibility of a genetic predisposition to chronic inflammatory disease <xref ref-type="bibr" rid="scirp.143790-3">
     [3]
    </xref>. This chronic inflammation over the years can lead to cancerous lesions and, with persistent HPV infection, These two previous interesting studies have given us information on the absence and presence of certain KIR genes, but it should be remembered that these are cases of precancerous lesions (CIN 1 and CIN 2), whereas our cases were HPV infectious status, which does not necessarily lead to the CIN stage or even cancer due to viral clearance <xref ref-type="bibr" rid="scirp.143790-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.143790-13">
     [13]
    </xref>. In Brazil, 79 women infected with HPV and 150 uninfected took part in a study to see the association between HPV and the genes of the immune response <xref ref-type="bibr" rid="scirp.143790-38">
     [38]
    </xref>. It was found that the KIR genes are not associated with HPV, although certain pairs of inhibitory KIR ligands are more common in patients, which supports the role of NK in harmful inflammation and chronic carcinogenesis. Our results are also different from those of Song in Korean women. No relationship between KIR genes and HPV-related cervical disease was found but a significant relationship was found between HLA-C alleles as ligands in KIR and HPV-related cervical disease <xref ref-type="bibr" rid="scirp.143790-39">
     [39]
    </xref>. HLA-C * 0303 was found to confer susceptibility to HPV-related cervical disease, while HLA-C * 01 was found to confer a protective effect against HPV-related cervical disease <xref ref-type="bibr" rid="scirp.143790-39">
     [39]
    </xref> while Rizzo showed that HLA-C and KIR typing is a marker for the risk of HPV infection and the progression of the lesion <xref ref-type="bibr" rid="scirp.143790-40">
     [40]
    </xref>. Indeed, as in our study, Rizzo et al. found an increase in the KIR 2DL3 gene in cases compared to controls. But it was in association with HLA-C1 <xref ref-type="bibr" rid="scirp.143790-40">
     [40]
    </xref>.</p>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>This study shows that the HR-HPV genotypes circulating in our regions are not dominated by genotypes 16 and 18 among asymptomatic women. This has implications for vaccine use to prevent infection. It would be interesting to get pharmaceutical companies to develop polyvalent broad-spectrum anti-HPV vaccines taking into account all the HPV-HR genotypes found in studies from the West Africa region. Studies on KIR genes give a first insight into their distribution in this West African population. The inhibitory KIR genes, KIR2DL3, KIR2DL4, KIR2DL5, KIR3DL2 and the pseudogene KIR2DP1 were statistically associated with HPV infection. KIR/HLA studies combined with additional genotyping are needed to investigate the molecular mechanisms by which KIR genes contribute to infection or elimination of HPV.</p>
  </sec><sec id="s6">
   <title>Acknowledgements</title>
   <p>We thank the “International Center for Genetic Engineering and Biotechnology (ICGEB)” for funding this research work through the project: “Implication of the host genetic factor in Human Papillomavirus Infection and its Associated Cervical Lesions and cancer in West African Women”. Ref. No. CRP/BFA17-01. We also thank the Agence Universitaire de la Francophonie (AUF) for the financial support. We thank also the UNESCO chaire in “Génie génétique et Biologie Moléculaire” for the technical support.</p>
  </sec><sec id="s7">
   <title>Data Availability</title>
   <p>The authors declare that there is no conflict of interest regarding the publication of this article.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.143790-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cerwenka, A. and Lanier, L.L. (2001) Natural Killer Cells, Viruses and Cancer. Nature Reviews Immunology, 1, 41-49. &gt;https://doi.org/10.1038/35095564
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wilson, M.J., Torkar, M., Haude, A., Milne, S., Jones, T., Sheer, D., et al. (2000) Plasticity in the Organization and Sequences of Human KIR/ILT Gene Families. Proceedings of the National Academy of Sciences of the United States of America, 97, 4778-4783. &gt;https://doi.org/10.1073/pnas.080588597
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tembhurne, A.K., Maheshwari, A., Warke, H., Chaudhari, H., Kerkar, S.C., Deodhar, K., et al. (2022) Killer Cell Immunoglobulin‐like Receptor (KIR) Gene Contents: Are They Associated with Cervical Cancer? Journal of Medical Virology, 95, e27873. &gt;https://doi.org/10.1002/jmv.27873
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Augusto, D.G. (2016) The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined? Frontiers in Genetics, 7, Article 121. &gt;https://doi.org/10.3389/fgene.2016.00121
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Augusto, D.G., Lobo-Alves, S.C., Melo, M.F., Pereira, N.F. and Petzl-Erler, M.L. (2012) Activating KIR and HLA Bw4 Ligands Are Associated to Decreased Susceptibility to Pemphigus Foliaceus, an Autoimmune Blistering Skin Disease. PLOS ONE, 7, e39991. &gt;https://doi.org/10.1371/journal.pone.0039991
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Augusto, D.G., Zehnder-Alves, L., Pincerati, M.R., Martin, M.P., Carrington, M. and Petzl-Erler, M.L. (2011) Diversity of the KIR Gene Cluster in an Urban Brazilian Population. Immunogenetics, 64, 143-152. &gt;https://doi.org/10.1007/s00251-011-0565-1
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hollenbach, J.A., Augusto, D.G., Alaez, C., Bubnova, L., Fae, I., Fischer, G., et al. (2012) 16
     <sup>th</sup> IHIW: Population Global Distribution of Killer Immunoglobulin-Like Receptor (KIR) and Ligands. International Journal of Immunogenetics, 40, 39-45. &gt;https://doi.org/10.1111/iji.12028
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Norman, P.J., Carrington, C.V.F., Byng, M., Maxwell, L.D., Curran, M.D., Stephens, H.A.F., et al. (2002) Natural Killer Cell Immunoglobulin-Like Receptor (KIR) Locus Profiles in African and South Asian Populations. Genes&amp;Immunity, 3, 86-95. &gt;https://doi.org/10.1038/sj.gene.6363836
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Chandanayingyong, D., Vaughan, R.W., Verity, D.H., Norman, P.J. and Stephens, H.A.F. (2001) Distribution of Natural Killer Cell Immunoglobulin-Like Receptor Sequences in Three Ethnic Groups. Immunogenetics, 52, 195-205. &gt;https://doi.org/10.1007/s002510000281
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     González-Galarza, F.F., Takeshita, L.Y.C., Santos, E.J.M., Kempson, F., Maia, M.H.T., Silva, A.L.S.D., et al. (2014) Allele Frequency Net 2015 Update: New Features for HLA Epitopes, KIR and Disease and HLA Adverse Drug Reaction Associations. Nucleic Acids Research, 43, D784-D788. &gt;https://doi.org/10.1093/nar/gku1166
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Arnheim, L., Dillner, J. and Sanjeevi, C.B. (2005) A Population-Based Cohort Study of kir Genes and Genotypes in Relation to Cervical Intraepithelial Neoplasia. Tissue Antigens, 65, 252-259. &gt;https://doi.org/10.1111/j.1399-0039.2005.00359.x
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Brestovac, B., Harnett, G.B., Smith, D.W., Shellam, G.R. and Frost, F.A. (2005) Human Papillomavirus Genotypes and Their Association with Cervical Neoplasia in a Cohort of Western Australian Women. Journal of Medical Virology, 76, 106-110. &gt;https://doi.org/10.1002/jmv.20330
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Brestovac, B., Wong, M.E., Tjendera, R., Costantino, P.J., Mamotte, C. and Witt, C.S. (2013) Human Papillomavirus, High-Grade Intraepithelial Neoplasia and Killer Immunoglogulin-Like Receptors: A Western Australian Cohort Study. Infectious Agents and Cancer, 8, Article No. 33. &gt;https://doi.org/10.1186/1750-9378-8-33
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Mhandire, K., Zijenah, L.S., Yindom, L., Duri, K., Mlambo, T., Tshabalala, M., et al. (2016) KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection against Human Immunodeficiency Virus Infection? OMICS: A Journal of Integrative Biology, 20, 727-735. &gt;https://doi.org/10.1089/omi.2016.0154
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Naranbhai, V., de Assis Rosa, D., Werner, L., Moodley, R., Hong, H., Kharsany, A., et al. (2015) Killer-Cell Immunoglobulin-Like Receptor (KIR) Gene Profiles Modify HIV Disease Course, Not HIV Acquisition in South African Women. BMC Infectious Diseases, 16, Article No. 27. &gt;https://doi.org/10.1186/s12879-016-1361-1
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sorgho, A.P., Martinson, J.J., Djigma, F.W., Yonli, A.T., Nagalo, B.M., Compaore, R.T., et al. (2018) Insights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina Faso. Mediterranean Journal of Hematology and Infectious Diseases, 10, e2018060. &gt;https://doi.org/10.4084/mjhid.2018.060
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Yindom, L., de Silva, T.I. and Rowland-Jones, S.L. (2015) Identification of a Novel Three-Domain KIR Allele: KIR3DL1*087 Using High-Resolution Molecular Techniques. Tissue Antigens, 85, 153-154. &gt;https://doi.org/10.1111/tan.12502
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Yindom, L., de Silva, T.I. and Rowland-Jones, S.L. (2015) KIR3DL1*0250102: A Novel Three-Domain KIR Subtype Identified in West Africa. Tissue Antigens, 85, 151-152. &gt;https://doi.org/10.1111/tan.12501
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Leone, P., De Re, V., Vacca, A., Dammacco, F. and Racanelli, V. (2017) Cancer Treatment and the KIR-HLA System: An Overview. Clinical and Experimental Medicine, 17, 419-429. &gt;https://doi.org/10.1007/s10238-017-0455-4
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ilboudo, R., et al. (2020) Prevalence and Characterization of High-Risk Human Papilloma-Virus Genotypes among a Group of Sex Workers in Ouagadougou, Burkina Faso. EC Gynaecology, 9, 1-9.
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Djigma, F.W., Ouédraogo, C., Karou, D.S., Sagna, T., Bisseye, C., Zeba, M., et al. (2011) Prevalence and Genotype Characterization of Human Papillomaviruses among HIV-Seropositive in Ouagadougou, Burkina Faso. Acta Tropica, 117, 202-206. &gt;https://doi.org/10.1016/j.actatropica.2010.12.007
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ouedraogo, C.M., et al. (2015) [Epidemiology and Characterization of High-Risk Genotypes of Human Papillomavirus in a Population of Sexually Active Adolescents in Ouagadougou]. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 44, 715-722.
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ouedraogo, R.A., Zohoncon, T.M., Guigma, S.P., Angèle Traore, I.M., Ouattara, A.K., Ouedraogo, M., et al. (2018) Oncogenic Human Papillomavirus Infection and Genotypes Characterization among Sexually Active Women in Tenkodogo at Burkina Faso, West Africa. Papillomavirus Research, 6, 22-26. &gt;https://doi.org/10.1016/j.pvr.2018.09.001
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Prosper, B., Florencia, D.W., Mahoukèdè, Z.T., Dorcas, O., Alima, T.E.M., Karim, O.A., et al. (2020) Polymorphism of MMP1 and MMP3 Promoter Regions and HR-HPV Infection in Women from Burkina Faso and Côte d’Ivoire. Biomolecular Concepts, 11, 116-124. &gt;https://doi.org/10.1515/bmc-2020-0010
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Traore, I.M.A., Zohoncon, T.M., Dembele, A., Djigma, F.W., Obiri-Yeboah, D., Traore, G., et al. (2016) Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso. BioMed Research International, 2016, Article ID: 7092583. &gt;https://doi.org/10.1155/2016/7092583
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Traore, I.M.A., Zohoncon, T.M., Ndo, O., Djigma, F.W., Obiri-Yebo, D., Compaore, T.R., et al. (2016) Oncogenic Human Papillomavirus Infection and Genotype Characterization among Women in Orodara, Western Burkina Faso. Pakistan Journal of Biological Sciences, 19, 306-311. &gt;https://doi.org/10.3923/pjbs.2016.306.311
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zohoncon, T.M. and Simpore, J. (2013) Prevalence of HPV High-Risk Genotypes in Three Cohorts of Women in Ouagadougou (Burkina Faso). Mediterranean Journal of Hematology and Infectious Diseases, 5, e2013059. &gt;https://doi.org/10.4084/mjhid.2013.059
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zohoncon, T.M., Ouedraogo, T.C., Brun, L.V.C., Obiri-Yebo, D., Djigma, W.F., Kabibou, S., et al. (2016) Molecular Epidemiology of High-Risk Human Papillomavirus in High-Grade Cervical Intraepithelial Neoplasia and in Cervical Cancer in Parakou, Republic of Benin. Pakistan Journal of Biological Sciences, 19, 49-56. &gt;https://doi.org/10.3923/pjbs.2016.49.56
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref29">
    <label>29</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zohoncon, T.M.B., et al. (2016) Molecular Characterization of High-Risk Human Papillomavirus Genotypes Involved in Invasive Cervical Cancer from Formalin-Fixed, Paraffin-Embedded Tissues in Ouagadougou, Burkina Faso. International Journal of Current Research, 8, 39314-39318.
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref30">
    <label>30</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Salambanga, C., et al. (2019) High Prevalence of High-Risk Human Papillomavirus (HPV) Infection among Sexually Active Women in Ouagadougou. Médecine et Santé Tropicales, 29, 302-305.
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref31">
    <label>31</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lanier, L.L. (2005) NK CELL Recognition. Annual Review of Immunology, 23, 225-274. &gt;https://doi.org/10.1146/annurev.immunol.23.021704.115526
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref32">
    <label>32</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Contreras, G., Aláez, C., Murguía, A., García, D., Flores, H. and Gorodezky, C. (2007) Distribution of the Killer Cell Immunoglobulin-Like Receptors in Mexican Mestizos. Tissue Antigens, 69, 125-129. &gt;https://doi.org/10.1111/j.1399-0039.2006.76212.x
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref33">
    <label>33</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Augusto, D.G., Norman, P.J., Dandekar, R. and Hollenbach, J.A. (2019) Fluctuating and Geographically Specific Selection Characterize Rapid Evolution of the Human KIR Region. Frontiers in Immunology, 10, Article 989. &gt;https://doi.org/10.3389/fimmu.2019.00989
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref34">
    <label>34</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Denis, L., Sivula, J., Gourraud, P.‐., Kerdudou, N., Chout, R., Ricard, C., et al. (2005) Genetic Diversity of KIR Natural Killer Cell Markers in Populations from France, Guadeloupe, Finland, Senegal and Réunion. Tissue Antigens, 66, 267-276. &gt;https://doi.org/10.1111/j.1399-0039.2005.00473.x
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref35">
    <label>35</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nakimuli, A., Chazara, O., Farrell, L., Hiby, S.E., Tukwasibwe, S., Knee, O., et al. (2013) Killer Cell Immunoglobulin-Like Receptor (KIR) Genes and Their HLA-C Ligands in a Ugandan Population. Immunogenetics, 65, 765-775. &gt;https://doi.org/10.1007/s00251-013-0724-7
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref36">
    <label>36</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gentle, N.L., Loubser, S., Paximadis, M., Puren, A. and Tiemessen, C.T. (2017) Killer-cell Immunoglobulin-Like Receptor (KIR) and Human Leukocyte Antigen (HLA) Class I Genetic Diversity in Four South African Populations. Human Immunology, 78, 503-509. &gt;https://doi.org/10.1016/j.humimm.2017.05.006
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref37">
    <label>37</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bani, M., Seket, J., Kaabi, H., Cherif, G., Chaabane, M., Bellali, H., et al. (2015) Killer Cell Immunoglobulin-Like Receptor (KIR) Locus Profiles in the Tunisian Population. Human Immunology, 76, 355-361. &gt;https://doi.org/10.1016/j.humimm.2015.03.002
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref38">
    <label>38</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Marangon, A.V., Guelsin, G.A.S., Visentainer, J.E.L., Borelli, S.D., Watanabe, M.A.E., Consolaro, M.E.L., et al. (2013) The Association of the Immune Response Genes to Human Papillomavirus-Related Cervical Disease in a Brazilian Population. BioMed Research International, 2013, Article ID: 146079. &gt;https://doi.org/10.1155/2013/146079
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref39">
    <label>39</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Song, M.J., Lee, C.W., Kim, J.H., Lee, S.J., Kim, C.J., Hur, S.Y., et al. (2013) Association of KIR Genes and HLA-C Alleles with HPV-Related Uterine Cervical Disease in Korean Women. Tissue Antigens, 81, 164-170. &gt;https://doi.org/10.1111/tan.12068
    </mixed-citation>
   </ref>
   <ref id="scirp.143790-ref40">
    <label>40</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rizzo, R., Gentili, V., Rotola, A., Bortolotti, D., Cassai, E. and Di Luca, D. (2014) Implication of HLA-C and KIR Alleles in Human Papillomavirus Infection and Associated Cervical Lesions. Viral Immunology, 27, 468-470. &gt;https://doi.org/10.1089/vim.2014.0017
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>